The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence.,, ...

Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...

Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens for cataract patients. The lens is described as the first of its kind in the ...

TECNIS PureSee IOL197% of patients would recommend this IOL to friends or family2TECNIS PureSee IOL is the first and only U.S. FDA-approved extended depth of focus (EDOF) IOL maintaining contrast ...

Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...

The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.

Cataract surgery remains one of the most frequently performed ophthalmic procedures worldwide, with continual refinements in surgical methods and intraocular lens (IOL) technology contributing to ...

Celebrating 75 years of intraocular lens advancements that have improved care for millions of cataract patients. On November 29, 1949, Sir Harold Ridley performed a surgical procedure to replace a ...

Here are 17 facts and business and legal issues about premium intraocular lenses, a recent technology that can free many cataract surgery patients from having to wear eyeglasses. 1. In one of the few ...

The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to ...